[
  {
    "ts": "2025-11-07T03:21:17+00:00",
    "headline": "Jim Cramer Says Pfizer “Will Continue to Sell at Eight Times Earnings”",
    "summary": "Pfizer Inc. (NYSE:PFE) is one of the stocks highlighted as Jim Cramer responded to questions from Harvard Business School students. A student asked if the stock, given the company’s reputation for innovation, its decline of over 50% from its peak, and recent deals involving Metsera and the Trump administration on drug pricing, is now a […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-says-pfizer-continue-032117950.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "95bbdb6e-f6c6-3f90-88f0-a6ea628e082a",
      "content": {
        "id": "95bbdb6e-f6c6-3f90-88f0-a6ea628e082a",
        "contentType": "STORY",
        "title": "Jim Cramer Says Pfizer “Will Continue to Sell at Eight Times Earnings”",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) is one of the stocks highlighted as Jim Cramer responded to questions from Harvard Business School students. A student asked if the stock, given the company’s reputation for innovation, its decline of over 50% from its peak, and recent deals involving Metsera and the Trump administration on drug pricing, is now a […]",
        "pubDate": "2025-11-07T03:21:17Z",
        "displayTime": "2025-11-07T03:21:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/bede06ab4149315d5115f133c0b1480c",
          "originalWidth": 1920,
          "originalHeight": 1272,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lBNvOkwEcDTC6JSi8u6u5Q--~B/aD0xMjcyO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/bede06ab4149315d5115f133c0b1480c.cf.webp",
              "width": 1920,
              "height": 1272,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l4R272WQ4gg_U7DbC5QzrA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bede06ab4149315d5115f133c0b1480c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-pfizer-continue-032117950.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-pfizer-continue-032117950.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-07T10:30:00+00:00",
    "headline": "This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed.",
    "summary": "The founders of Metsera have a battle to buy their company. It would be their second time striking deal gold.",
    "url": "https://www.wsj.com/health/pharma/metsera-pfizer-bid-weight-loss-drugs-e95dadcc?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "04f80ce8-0931-3b97-9f3c-4de6cb72d189",
      "content": {
        "id": "04f80ce8-0931-3b97-9f3c-4de6cb72d189",
        "contentType": "STORY",
        "title": "This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed.",
        "description": "",
        "summary": "The founders of Metsera have a battle to buy their company. It would be their second time striking deal gold.",
        "pubDate": "2025-11-07T10:30:00Z",
        "displayTime": "2025-11-07T10:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/04f80ce8-0931-3b97-9f3c-4de6cb72d189/this-unlikely-duo-is.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/6733447ed0f1fbe1f832faffd6c0e15d",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iMbL84xpcQXGNaDasIdrsA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/6733447ed0f1fbe1f832faffd6c0e15d.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DKP9j8iYwslqMrh5vgFjtQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/6733447ed0f1fbe1f832faffd6c0e15d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/metsera-pfizer-bid-weight-loss-drugs-e95dadcc?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVN.SW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]